Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
215
-
Total 13F shares, excl. options
-
91,152,820
-
Shares change
-
+1,834,128
-
Total reported value, excl. options
-
$1,472,210,430
-
Value change
-
-$63,470,630
-
Put/Call ratio
-
76.65%
-
Number of buys
-
110
-
Number of sells
-
-138
-
Price
-
$16.15
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q3 2023
333 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q3 2023.
NovoCure Ltd - Common Stock (NVCR) has 215 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91,152,820 shares
of 111,111,111 outstanding shares and own 82.04% of the company stock.
Largest 10 shareholders include FMR LLC (15,959,548 shares), VANGUARD GROUP INC (9,636,993 shares), Capital International Investors (9,004,492 shares), Capital World Investors (8,878,731 shares), BlackRock Inc. (7,862,381 shares), BAILLIE GIFFORD & CO (6,814,214 shares), Deep Track Capital, LP (2,500,000 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,364,459 shares), STATE STREET CORP (2,092,622 shares), and VOLORIDGE INVESTMENT MANAGEMENT, LLC (1,706,588 shares).
This table shows the top 215 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.